These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6273456

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects.
    Peterson LR, Gerding DN, Van Etta LL, Eckfeldt JH, Larson TA.
    Antimicrob Agents Chemother; 1982 Nov; 22(5):878-81. PubMed ID: 6295270
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.
    Pollock AA, Tee PE, Patel IH, Spicehandler J, Simberkoff MS, Rahal JJ.
    Antimicrob Agents Chemother; 1982 Nov; 22(5):816-23. PubMed ID: 6295268
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Fundamental and clinical studies of ceftizoxime in obstetrical and gynecological field].
    Hayasaki M, Iwasa S, Kondo H, Itoh K, Noda K.
    Jpn J Antibiot; 1982 Sep; 35(9):2252-76. PubMed ID: 6292542
    [Abstract] [Full Text] [Related]

  • 30. Susceptibility of Neisseria gonorrhoeae to ceftizoxime in vitro and in vivo.
    Korting HC, Neubert U.
    Chemotherapy; 1984 Sep; 30(5):322-7. PubMed ID: 6092006
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of ethyl cellulose in a medium-chain triglyceride on the bioavailability of ceftizoxime.
    Ueda I, Shimojo F, Kozatani J.
    J Pharm Sci; 1983 Apr; 72(4):454-8. PubMed ID: 6306204
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics of ceftizoxime.
    Cutler RE, Blair AD, Burgess ED, Parks D.
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():91-7. PubMed ID: 6296034
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
    Burgess ED, Blair AD.
    Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adults.
    Fourtillan JB, Bryskier A, Mignot A, Borsa F, Humbert G.
    Am J Med; 1984 Dec 21; 77(6A):28-31. PubMed ID: 6097120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.